​​​THE KETAMINE EXPERIENCE

 

Subjective and Psychological Effects

At sub-anesthetic doses, ketamine produces dissociation—a sense of detachment from body, identity, and physical space. Users often describe it as “stepping outside of self” or “floating through thought.”

 

The experience may include:

• Visual and auditory distortions

• Altered body perception (out-of-body or “weightless” sensations)

• Emotional detachment followed by catharsis

• Nonlinear thought, introspective imagery

• Experiences of unity or “ego dissolution” at higher doses

 

These states can be both therapeutic and disorienting, depending on setting and intention.​​

​

​​KETAMINE THERAPY

 

Ketamine-assisted psychotherapy (KAP) integrates the pharmacological action of ketamine with psychological support before, during, and after the session. Studies suggest the combination enhances emotional processing and integration, particularly in treatment-resistant depression, PTSD, and anxiety disorders.

 

Key Clinical Findings

• Rapid reduction in depressive symptoms, often within hours. (Berman et al., 2000, Biol Psychiatry)

• Significant anti-suicidal effects lasting up to a week post-administration. (Zarate et al., 2006, Arch Gen Psychiatry)

• Potential benefits for chronic pain, OCD, and trauma-related disorders. (Dore et al., 2019, J Psychoactive Drugs)

 

While results are promising, questions remain regarding long-term efficacy, optimal dosing, and risk of tolerance or dependence.

​

FUTURE DIRECTIONS IN RESEARCH

Ongoing research is exploring:

• Mechanisms underlying rapid antidepressant and neuroplastic effects

• Potential of R- vs. S-ketamine enantiomers

• Long-term outcomes of repeated KAP treatments

• Combinations of ketamine with mindfulness or virtual reality therapy

• Microdosing protocols (still experimental and unvalidated)

​

KETAMINE'S LEGAL STATUS & ACCESS

 

Ketamine is a Schedule III controlled substance in the United States, meaning it has recognized medical use but is tightly regulated. Esketamine (Spravato) is FDA-approved for treatment-resistant depression and administered under medical supervision.

Outside prescription frameworks, ketamine clinics and telehealth providers (for oral or sublingual lozenges) have expanded rapidly, though oversight varies.

​​​

ACCESSING THERAPY

​​​​

RISKS, SIDE EFFECTS & CONTRAINDICATIONS

​

Although safer than many anesthetics, ketamine is not without risk—especially outside medical contexts.

 

Common Side Effects

• Dizziness, nausea, blurred vision

• Transient anxiety, confusion, or disorientation

• Increased heart rate and blood pressure

• Nystagmus (rapid eye movement) and slurred speech

 

Serious Risks

• Cardiovascular stress in people with heart disease

• Bladder and urinary tract damage with chronic use (“ketamine cystitis”)

• Dependence or tolerance in recreational users

• Psychological disorientation or distress at high doses

 

Contraindications

• Uncontrolled hypertension or heart disease

• Active psychosis, schizophrenia, or mania

• Pregnancy or lactation (insufficient safety data)

• Concurrent use of CNS depressants or MAOIs​​

​

KETAMINE & SPIRITUALITY

 

Many report ketamine as a “portal” to non-ordinary awareness—a liminal state between anesthesia and transcendence. Experiences often evoke:

• Detachment from ego and material identity

• Encounters with archetypal or cosmic imagery

• Profound emotional release or forgiveness

• A sense of universal unity or “light immersion”

 

Spiritual experiences under ketamine can feel similar to those induced by DMT or psilocybin, though generally less sensory and more spatial or existential in tone. Integration is essential for translating these states into meaningful psychological growth.

​​​

MICRODOSING KETAMINE

​​​​

PREPARING FOR YOUR KETAMINE SESSION

​​

Whether in a clinical or intentional setting, preparation greatly influences safety and outcome.

Before your session:

• Set a clear intention (healing, self-inquiry, trauma work, etc.)

• Abstain from alcohol or drugs for 24–48 hours

• Eat lightly before administration

• Ensure emotional and environmental safety

During the session:

• Use an eye mask and calming music for inner focus

• Have a trusted sitter or therapist present if possible

• Avoid external stimulation; allow the experience to unfold

After the session:

• Journal insights immediately after emerging

• Integrate with therapy, meditation, or nature time

• Rest and hydrate; emotional processing may continue for days

​

WHAT TO EXPECT DURING YOUR KETAMINE SESSION

 

HARM REDUCTION & BEST PRACTICES

• Only use ketamine in safe, supervised, and legal contexts.

• Start with low doses to assess sensitivity.

• Avoid mixing with alcohol, benzodiazepines, or opioids.

• Allow at least one week between sessions to avoid tolerance.

• Prioritize integration work (therapy, journaling, support groups).

​

INTEGRATING THE EXPERIENCE

​​

References & Further Reading

1. Berman, R.M. et al. (2000). “Antidepressant Effects of Ketamine in Depressed Patients.” Biological Psychiatry, 47(4): 351–354.

2. Zarate, C.A. et al. (2006). “A Randomized Trial of an NMDA Antagonist in Treatment-Resistant Major Depression.” Arch Gen Psychiatry, 63(8): 856–864.

3. Dore, J. et al. (2019). “Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression.” J Psychoactive Drugs, 51(2): 155–165.

4. Krystal, J.H. et al. (1994). “Subanesthetic Effects of Ketamine in Humans.” Archives of General Psychiatry, 51(3): 199–214.

5. Sanacora, G. et al. (2021). “Ketamine and Esketamine: The Dawn of a New Era for Depression Treatment.” JAMA Psychiatry.

6. NIMH (2023). “Ketamine for Depression: What We Know.” National Institute of Mental Health.